Statistics for Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
Total visits
| views | |
|---|---|
| Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA | 30 |
Total visits per month
| views | |
|---|---|
| November 2024 | 2 |
| December 2024 | 6 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant_a study based on molecular docking, molecular dynamics.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 10 |
| China | 7 |
| Australia | 5 |
| Portugal | 4 |
| Brazil | 1 |
| Canada | 1 |
| India | 1 |
| Mongolia | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Flushing | 1 |